| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964646 | Vaccine | 2014 | 5 Pages |
Abstract
TIV and ATIV reduce hospitalization for influenza or pneumonia with a variable degree of protection in different age groups. In particular, ATIV is more effective in individuals over 75 years old.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A. Spadea, B. Unim, V. Colamesta, A. Meneghini, A.M. D'Amici, B. Giudiceandrea, G. La Torre,